In May, our doctoral student Maria Braun Cornejo, half German, half Spanish, tells us about her time at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Germany.
Concluding his participation in our blog this year, our doctoral student Daan tells us about the new visiting researchers at HIPS and his last endeavors.
In April, our doctoral student Daan Willocx, from Belgium, tells us about his time at the headquarters of Drug for Neglected Diseases Initiative (DNDi), Switzerland.
Concluding her participation in our blog this year, our doctoral student Lucia tells us about the Institut de Biologie Structurale, her research group, learning French and an event she is looking forward to.
In March, our doctoral student Lucia D’Auria, from Italy, tells us about her time in the biological chemistry and therapeutic applications (CBAT) group at the University of Strasbourg, France.
Concluding her participation in our blog this year, our doctoral student Bruna tells us about her research group at the University of Bergen and the meeting she attended in Tromsø.
In February, our doctoral student Bruna Schuck, from Brazil, tells us about the time she spent at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Germany.
Get to know our researchers on our biweekly blog. Each month, a different PhD will share their personal experiences and opinions about their research.
This year we start sharing the experiences from our secondments. It’s an opportunity to work in a different environment within our consortium, be exposed to a new culture, and learn new skills.
In January, our doctoral student Antoine Lacour, from France, tells us about the time he spent at the University of Bergen (Norway), performing biological experiments such as protein expression and purification, stability assay, and binding constant determination using Bio-Layer Interferometry (BLI).
Concluding her participation in our blog this year, our doctoral student Maria shares her role within the MepAnti consortium and how she makes compounds that could lead to a drug candidate.
Stay tuned for next year’s blog with the opinions and personal experiences of our PhDs.